Epilim Intravenous 400 mg powder and solvent for solution for injection or infusion, Corrected reconstitution instructions
16/04/2025
Medicines for human use
Product information update (PIU)
This update is to inform healthcare professionals that the reconstitution instructions have been corrected in the product information for Epilim Intravenous 400 mg powder and solvent for solution for injection or infusion (PA0540/150/013).
Product information
- Active substance
- Sodium valproate
- Authorisation holder
- Sanofi-aventis Ireland Limited
- Authorisation number
- PA0540/150/013
- Human or veterinary medicine
- Human Medicine